Vaccine Administration Decision Making: The Case of Yellow Fever Vaccine | Zendy

Beth A. Lown | Zendy; Lin H. Chen | Zendy; Mary Wilson | Zendy; Emily Sisson | Zendy; Mark D. Gershman | Zendy; Emad Yanni | Zendy; Emily S. Jentes | Zendy; Natasha S. Hochberg | Zendy; Davidson H. Hamer | Zendy; Elizabeth D. Barnett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vaccine Administration Decision Making: The Case of Yellow Fever Vaccine

Author(s) -

Beth A. Lown,

Lin H. Chen,

Mary Wilson,

Emily Sisson,

Mark D. Gershman,

Emad Yanni,

Emily S. Jentes,

Natasha S. Hochberg,

Davidson H. Hamer,

Elizabeth D. Barnett

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis520

Subject(s) - medicine , yellow fever vaccine , adverse effect , decision aids , disease , family medicine , medical emergency , yellow fever , immunology , alternative medicine , virus , pathology

Providers must counsel travelers to yellow fever (YF)-endemic areas, although risk estimates of disease and vaccine serious adverse events (SAEs) may be imprecise. The impact of risk information and patients' requests for participation in vaccine decisions on providers' recommendations is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research